- Contains 2 clinically proven probiotic strains
- Over 20 years of research support the oral
use of GR-1 and RC14 to colonize and
protect the vaginal tract
- Support the health of urinary tract

Usage: Take 1 capsule daily for maintenance and increase to 2
capsules a day as needed, or use as directed by your qualified
health care consultant.


fem-dophilus™ contains two Probiotic Formula patented and
clinically proven probiotic strains, Lactobacillus GR-1™ and
Lactobacillus RC-14®, discovered and developed by Dr. Gregor
Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of
research supports the oral use of GR-1™ and RC-14® to
colonize and protect the vaginal tract.*

Clinical trials have shown that GR-1™ and RC-14®:

Help to maintain or restore healthy vaginal flora which is
important in maintaining vaginal health*
Support the health of the urinary tract*
fem-dophilus™ is manufactured under pharmaceutical GMP
conditions wi th guaranteed potency and consistency. The
probiotic strains in fem-dophilus™ are in a proprietary
polysaccharide matrix, which protects the bacteria from stomach
acid and enhances probiotic bacteria survival to the lower
intestine.


Scientific References
1. FEMS Immunol Med Microbiol. 2001 Dec;32(1):37-41. Probiotic
Lactobacillus dose required to restore and maintain a normal vaginal flora.
Reid G et al.

2. FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):131-4. Oral use of
Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters
vaginal flora: randomized, placebo-controlled trial in 64 healthy women.
Reid G et al.

3. Clin Diagn Lab Immunol. 2002 Jan;9(1):92-6. Persistence of
Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not
L. rhamnosus GG in the human vagina as demonstrated by randomly
amplified polymorphic DNA.Gardiner GEAm J Clin Nutr. 2004 Dec;80(6):
1618-25.

4. Eur Rev Med Pharmacol Sci. 2004 Mar-Apr;8(2):87-95. Lactobacilli for
prevention of urogenital infections: a review.Marelli G, Papaleo E, Ferrari A.

5. FEMS Immunol Med Microbiol. 2001 Feb;30(1):49-52.
Oral probiotics can resolve urogenital infections. Reid G et al.

6. Crit Rev Food Sci Nutr. 2002;42(3 Suppl):293-300. The role of cranberry
and probiotics in intestinal and urogenital tract health. Reid G.


7. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in
stimulated CD4+ T cells via modulation of dendritic cell function. Braat H
et al. (anti infllammatory in mucosal cells)

8. Microbes Infect. 2006 Oct;8(12-13):2772-6. Epub 2006 Sep 11.
Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with
metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Anukam KC et al.
Jarrow's Formula's
Fem-Dophilus™
Promotes Vaginal Health Naturally
Introductory Price: $30
Supplement Facts
Serving size: 1 Capsule  
Servings Per Box: 30

Amount Per Serving   
Total Probiotic Bacteria           5 Billions cfu

Lactobacillus Rhamnosus GF-1 TM
Lactobacillus Reuteri RC14 R

Other Ingredients:
Dextrose anhydrate, potato starch,
microcrystalline cellulose and magnesium
stearate (vegetable source). Capsule consists
of gelatin and titanium dioxide.

No wheat, no gluten, no soy, no dairy, no
egg, no fish/shellfish, no nuts/tree nuts
Since 1986, Jarrow
Formulas has been a
pioneer in the field of
developing high-quality
probiotic supplements for
infants, children, adults,
women’s health, seniors,
and pets.

Along with the #1 Selling
Probiotic Product in the U.
S.*, Jarro-Dophilus
EPS™, Jarrow Formulas
now offers Fem-
Dophilus™, an oral
probiotic supplement for
women that has been
clinically documented to
help maintain and restore
a healthy microflora
throughout the vaginal
and urinary tracts.

Jarrow Formulas
continues to create new
probiotic products that
are on the leading edge
of current scientific
research. We strive to
deliver probiotic products
that have been clinically
shown to address the
varied health needs of
our loyal consumers.

*#1 in Sales Volume and
Units Sold, according to
SPINS, a market
research and consulting
firm for the Natural
Products Industry
(SPINScan Natural, 52
Weeks Ending 10/7/2006.
www.spins.com